Concurrently, Ganet treatment substantially reduced both total tumor burden (p = 0.0133, Fig. 7b-c) and liver metastasis (p = 0.018, Fig. 7d) without significant effects on tumors with stable, mutp53-independent ENTPD5 expression (Fig. 7b-d). The gene discussed is ENTPD5; the disease is neoplasm.